Large-scale testing (Phase 3)Study completedNCT03439657
What this trial is testing
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older
Who this might be right for
Herpes Zoster
GlaxoSmithKline 913